Your browser doesn't support javascript.
loading
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Zandberg, Dan P; Algazi, Alain P; Jimeno, Antonio; Good, James S; Fayette, Jérôme; Bouganim, Nathaniel; Ready, Neal E; Clement, Paul M; Even, Caroline; Jang, Raymond W; Wong, Stuart; Keilholz, Ulrich; Gilbert, Jill; Fenton, Moon; Braña, Irene; Henry, Stephanie; Remenar, Eva; Papai, Zsuzsanna; Siu, Lillian L; Jarkowski, Anthony; Armstrong, Jon M; Asubonteng, Kobby; Fan, Jean; Melillo, Giovanni; Mesía, Ricard.
Afiliación
  • Zandberg DP; University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, USA. Electronic address: zandbergdp@upmc.edu.
  • Algazi AP; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
  • Jimeno A; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Good JS; Institute of Head and Neck Studies and Education, Queen Elizabeth Hospital, Birmingham, UK.
  • Fayette J; Clinical Oncology, Cancer Center Centre Léon Bérard, University of Lyon, Lyon, France.
  • Bouganim N; Department of Oncology, McGill University Health Centre, Montréal, QC, Canada.
  • Ready NE; Duke University Medical Center, Durham, NC, USA.
  • Clement PM; Department of Oncology, Leuven Cancer Institute, KU Leuven, Belgium.
  • Even C; Department of Head and Neck Oncology, Institut Gustave Roussy, Villejuif, France.
  • Jang RW; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Wong S; Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Keilholz U; Charité Comprehensive Cancer Center, Berlin, Germany.
  • Gilbert J; Henry-Joyce Cancer Clinic, Nashville, TN, USA.
  • Fenton M; The West Cancer Center, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Braña I; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Henry S; Department of Oncology-Hematology, Radiotherapy, and Nuclear Medicine, CHU UCL Namur, Namur, Belgium.
  • Remenar E; National Institute of Oncology (Országos Onkológiai Intézet), Budapest, Hungary.
  • Papai Z; State Health, Center Higatian Defanse Forses, Budapest, Hungary.
  • Siu LL; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Jarkowski A; AstraZeneca, Gaithersburg, MD, USA.
  • Armstrong JM; AstraZeneca, Gaithersburg, MD, USA.
  • Asubonteng K; AstraZeneca, Gaithersburg, MD, USA.
  • Fan J; AstraZeneca, Gaithersburg, MD, USA.
  • Melillo G; AstraZeneca, Gaithersburg, MD, USA.
  • Mesía R; Medical Oncology Department, Catalan Institute of Oncology, University of Barcelona, IDIBELL, Barcelona, Spain.
Eur J Cancer ; 107: 142-152, 2019 01.
Article en En | MEDLINE | ID: mdl-30576970
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Recuperativa / Antígeno B7-H1 / Antineoplásicos Inmunológicos / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello / Anticuerpos Monoclonales / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Recuperativa / Antígeno B7-H1 / Antineoplásicos Inmunológicos / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello / Anticuerpos Monoclonales / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2019 Tipo del documento: Article